These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31620124)

  • 1. Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity.
    Tiwary S; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2187. PubMed ID: 31620124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.
    Terabe M; Berzofsky JA
    Cancer Immunol Immunother; 2014 Mar; 63(3):199-213. PubMed ID: 24384834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contrasting roles of NKT cells in tumor immunity.
    Berzofsky JA; Terabe M
    Curr Mol Med; 2009 Aug; 9(6):667-72. PubMed ID: 19689293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-Specific Roles of NKT Cells in Tumor Immunity.
    Terabe M; Berzofsky JA
    Front Immunol; 2018; 9():1838. PubMed ID: 30158927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties.
    Singh AK; Tripathi P; Cardell SL
    Front Immunol; 2018; 9():1969. PubMed ID: 30210505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NKT cells in tumor immunity.
    Terabe M; Berzofsky JA
    Adv Cancer Res; 2008; 101():277-348. PubMed ID: 19055947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
    Arrenberg P; Halder R; Kumar V
    J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors.
    Joyce S; Girardi E; Zajonc DM
    J Immunol; 2011 Aug; 187(3):1081-9. PubMed ID: 21772035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKT Cells Contribute to the Control of Microbial Infections.
    Vogt S; Mattner J
    Front Cell Infect Microbiol; 2021; 11():718350. PubMed ID: 34595131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
    Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
    Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.
    Kato S; Berzofsky JA; Terabe M
    Front Immunol; 2018; 9():314. PubMed ID: 29520281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary approaches to study NKT cells in cancer.
    Berzofsky JA; Olkhanud PB; Terabe M
    Methods Enzymol; 2020; 631():371-389. PubMed ID: 31948558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
    Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
    Front Immunol; 2020; 11():610010. PubMed ID: 33312179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice.
    VanderLaan PA; Reardon CA; Cabana VG; Wang CR; Getz GS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ins and outs of type I iNKT cell development.
    Shissler SC; Webb TJ
    Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II NKT Cells and Their Emerging Role in Health and Disease.
    Dhodapkar MV; Kumar V
    J Immunol; 2017 Feb; 198(3):1015-1021. PubMed ID: 28115591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing antigen recognition by Natural Killer T cells.
    Zeissig S; Olszak T; Melum E; Blumberg RS
    Methods Mol Biol; 2013; 960():557-572. PubMed ID: 23329514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
    Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
    Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.